MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

MOLECULAR PARTNERS AG

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026

$3.66+0.10 (+2.81%)

Close on Oct 19, 2026

MOLECULAR PARTNERS AG revenue by segment

Molecular Partners does not break out revenue by segment, region or product in the tagged data of its filings for this period type.